{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:34:54Z","timestamp":1791340494713,"version":"4.3.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,11,6]],"date-time":"2008-11-06T00:00:00Z","timestamp":1225929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,11,6]],"date-time":"2008-11-06T00:00:00Z","timestamp":1225929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1038\/leu.2008.320","type":"journal-article","created":{"date-parts":[[2008,11,6]],"date-time":"2008-11-06T10:49:35Z","timestamp":1225968575000},"page":"574-580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":200,"title":["Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas"],"prefix":"10.1038","volume":"23","author":[{"given":"A L","family":"Feldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E D","family":"Remstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W R","family":"Macon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L A","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K L","family":"Grogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P J","family":"Kurtin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,11,6]]},"reference":[{"key":"BFleu2008320_CR1","volume-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"ES Jaffe","year":"2001","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman J . Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, France, 2001."},{"key":"BFleu2008320_CR2","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/annonc\/mdh392","volume":"15","author":"KJ Savage","year":"2004","unstructured":"Savage KJ, Chhanabhai M, Gascoyne RD, Connors JM . Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol 2004; 15: 1467\u20131475.","journal-title":"Ann Oncol"},{"key":"BFleu2008320_CR3","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/leu.2008.77","volume":"22","author":"AL Feldman","year":"2008","unstructured":"Feldman AL, Sun DX, Law ME, Novak AJ, Attygalle AD, Thorland EC et al. Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas. Leukemia 2008; 22: 1139\u20131143.","journal-title":"Leukemia"},{"key":"BFleu2008320_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/sj.leu.2404045","volume":"20","author":"B Streubel","year":"2006","unstructured":"Streubel B, Vinatzer U, Willheim M, Raderer M, Chott A . Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 2006; 20: 313\u2013318.","journal-title":"Leukemia"},{"key":"BFleu2008320_CR5","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/med.20109","volume":"28","author":"R Li","year":"2008","unstructured":"Li R, Morris SW . Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy. Med Res Rev 2008; 28: 372\u2013412.","journal-title":"Med Res Rev"},{"key":"BFleu2008320_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/modpathol.3880289","volume":"14","author":"ES Jaffe","year":"2001","unstructured":"Jaffe ES . Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology. Mod Pathol 2001; 14: 219\u2013228.","journal-title":"Mod Pathol"},{"key":"BFleu2008320_CR7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1309\/N3GJ-N7A3-T98G-RYJL","volume":"118","author":"ME Lae","year":"2002","unstructured":"Lae ME, Ahmed I, Macon WR . Clusterin is widely expressed in systemic anaplastic large cell lymphoma but fails to differentiate primary from secondary cutaneous anaplastic large cell lymphoma. Am J Clin Pathol 2002; 118: 773\u2013779.","journal-title":"Am J Clin Pathol"},{"key":"BFleu2008320_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1177\/107327480701400205","volume":"14","author":"C Droc","year":"2007","unstructured":"Droc C, Cualing HD, Kadin ME . Need for an improved molecular\/genetic classification for CD30+ lymphomas involving the skin. Cancer Control 2007; 14: 124\u2013132.","journal-title":"Cancer Control"},{"key":"BFleu2008320_CR9","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1182\/blood-2007-04-060715","volume":"110","author":"HM Amin","year":"2007","unstructured":"Amin HM, Lai R . Pathobiology of ALK+ anaplastic large-cell lymphoma. Blood 2007; 110: 2259\u20132267.","journal-title":"Blood"},{"key":"BFleu2008320_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ng1097-226","volume":"17","author":"S Iida","year":"1997","unstructured":"Iida S, Rao PH, Butler M, Corradini P, Boccadoro M, Klein B et al. Deregulation of MUM1\/IRF4 by chromosomal translocation in multiple myeloma. Nat Genet 1997; 17: 226\u2013230.","journal-title":"Nat Genet"},{"key":"BFleu2008320_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1309\/PNXUKA1CFJMVGCN1","volume":"130","author":"AL Feldman","year":"2008","unstructured":"Feldman AL, Law M, Grogg KL, Thorland EC, Fink S, Kurtin PJ et al. Incidence of TCR and TCL1 gene translocations and isochromosome 7q in peripheral T-cell lymphomas using fluorescence in situ hybridization. Am J Clin Pathol 2008; 130: 178\u2013185.","journal-title":"Am J Clin Pathol"},{"key":"BFleu2008320_CR12","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1097\/01.pas.0000213275.60962.2a","volume":"30","author":"ED Remstein","year":"2006","unstructured":"Remstein ED, Dogan A, Einerson RR, Paternoster SF, Fink SR, Law M et al. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America. Am J Surg Pathol 2006; 30: 1546\u20131553.","journal-title":"Am J Surg Pathol"},{"key":"BFleu2008320_CR13","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1038\/sj.leu.2405027","volume":"22","author":"ED Remstein","year":"2008","unstructured":"Remstein ED, Law M, Mollejo M, Piris MA, Kurtin PJ, Dogan A . The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma. Leukemia 2008; 22: 1268\u20131272.","journal-title":"Leukemia"},{"key":"BFleu2008320_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/01.gim.0000195645.00446.61","volume":"8","author":"AE Wiktor","year":"2006","unstructured":"Wiktor AE, Van Dyke DL, Stupca PJ, Ketterling RP, Thorland EC, Shearer BM et al. Preclinical validation of fluorescence in situ hybridization assays for clinical practice. Genet Med 2006; 8: 16\u201323.","journal-title":"Genet Med"},{"key":"BFleu2008320_CR15","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/S0002-9440(10)61146-7","volume":"160","author":"SF Paternoster","year":"2002","unstructured":"Paternoster SF, Brockman SR, McClure RF, Remstein ED, Kurtin PJ, Dewald GW . A new method to extract nuclei from paraffin-embedded tissue to study lymphomas using interphase fluorescence in situ hybridization. Am J Pathol 2002; 160: 1967\u20131972.","journal-title":"Am J Pathol"},{"key":"BFleu2008320_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1309\/BLH8MMK85UBQ4K6R","volume":"124","author":"RR Einerson","year":"2005","unstructured":"Einerson RR, Kurtin PJ, Dayharsh GA, Kimlinger TK, Remstein ED . FISH is superior to PCR in detecting t(14;18)(q32;q21)-IgH\/bcl-2 in follicular lymphoma using paraffin-embedded tissue samples. Am J Clin Pathol 2005; 124: 421\u2013429.","journal-title":"Am J Clin Pathol"},{"key":"BFleu2008320_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/ajcp\/112.3.319","volume":"112","author":"PJ Kurtin","year":"1999","unstructured":"Kurtin PJ, Hobday KS, Ziesmer S, Caron BL . Demonstration of distinct antigenic profiles of small B-cell lymphomas by paraffin section immunohistochemistry. Am J Clin Pathol 1999; 112: 319\u2013329.","journal-title":"Am J Clin Pathol"},{"key":"BFleu2008320_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/modpathol.3801024","volume":"21","author":"AC Roden","year":"2008","unstructured":"Roden AC, Macon WR, Keeney GL, Myers JL, Feldman AL, Dogan A . Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol 2008; 21: 455\u2013463.","journal-title":"Mod Pathol"},{"key":"BFleu2008320_CR19","volume-title":"The AGT Cytogenetics Laboratory Manual","author":"M Barch","year":"1997","unstructured":"Barch M, Knutsen T, Spubeck J (eds). The AGT Cytogenetics Laboratory Manual. Lippincott-Raven: Philadelphia, PA, 1997."},{"key":"BFleu2008320_CR20","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/sj.leu.2403965","volume":"19","author":"G Roncador","year":"2005","unstructured":"Roncador G, Garcia JF, Maestre L, Lucas E, Menarguez J, Ohshima K et al. FOXP3, a selective marker for a subset of adult T-cell leukaemia\/lymphoma. Leukemia 2005; 19: 2247\u20132253.","journal-title":"Leukemia"},{"key":"BFleu2008320_CR21","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.V91.6.2076","volume":"91","author":"D Benharroch","year":"1998","unstructured":"Benharroch D, Meguerian-Bedoyan Z, Lamant L, Amin C, Brugieres L, Terrier-Lacombe MJ et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 1998; 91: 2076\u20132084.","journal-title":"Blood"},{"key":"BFleu2008320_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1046\/j.1365-2559.2000.00799.x","volume":"36","author":"ML Boulland","year":"2000","unstructured":"Boulland ML, Wechsler J, Bagot M, Pulford K, Kanavaros P, Gaulard P . Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins. Histopathology 2000; 36: 136\u2013144.","journal-title":"Histopathology"},{"key":"BFleu2008320_CR23","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/1523-1747.ep12337633","volume":"109","author":"JA Kummer","year":"1997","unstructured":"Kummer JA, Vermeer MH, Dukers D, Meijer CJ, Willemze R . Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype. J Invest Dermatol 1997; 109: 636\u2013640.","journal-title":"J Invest Dermatol"},{"key":"BFleu2008320_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0046-8177(99)90281-2","volume":"30","author":"RE Felgar","year":"1999","unstructured":"Felgar RE, Salhany KE, Macon WR, Pietra GG, Kinney MC . The expression of TIA-1+ cytolytic-type granules and other cytolytic lymphocyte-associated markers in CD30+ anaplastic large cell lymphomas (ALCL): correlation with morphology, immunophenotype, ultrastructure, and clinical features. Hum Pathol 1999; 30: 228\u2013236.","journal-title":"Hum Pathol"},{"key":"BFleu2008320_CR25","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","volume":"111","author":"KJ Savage","year":"2008","unstructured":"Savage KJ, Harris NL, Vose JM, Ullrich F, Jaffe ES, Connors JM et al. ALK\u2013\u2013anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood 2008; 111: 5496\u20135504.","journal-title":"Blood"},{"key":"BFleu2008320_CR26","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","volume":"95","author":"MW Bekkenk","year":"2000","unstructured":"Bekkenk MW, Geelen FA, van Voorst Vader PC, Heule F, Geerts ML, van Vloten WA et al. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 2000; 95: 3653\u20133661.","journal-title":"Blood"},{"key":"BFleu2008320_CR27","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1046\/j.1365-2559.2003.01726.x","volume":"43","author":"RL ten Berge","year":"2003","unstructured":"ten Berge RL, de Bruin PC, Oudejans JJ, Ossenkoppele GJ, van der Valk P, Meijer CK . ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified. Histopathology 2003; 43: 462\u2013469.","journal-title":"Histopathology"},{"key":"BFleu2008320_CR28","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1365-2141.2007.06924.x","volume":"140","author":"I Salaverria","year":"2008","unstructured":"Salaverria I, Bea S, Lopez-Guillermo A, Lespinet V, Pinyol M, Burkhardt B et al. Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas. Br J Haematol 2008; 140: 516\u2013526.","journal-title":"Br J Haematol"},{"key":"BFleu2008320_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/gcc.10184","volume":"37","author":"X Mao","year":"2003","unstructured":"Mao X, Orchard G, Lillington DM, Russell-Jones R, Young BD, Whittaker S . Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma. Genes Chromosomes Cancer 2003; 37: 176\u2013185.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFleu2008320_CR30","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.humpath.2005.03.004","volume":"36","author":"MA Thompson","year":"2005","unstructured":"Thompson MA, Stumph J, Henrickson SE, Rosenwald A, Wang Q, Olson S et al. Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas. Hum Pathol 2005; 36: 494\u2013504.","journal-title":"Hum Pathol"},{"key":"BFleu2008320_CR31","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1182\/blood.V95.6.2084","volume":"95","author":"B Falini","year":"2000","unstructured":"Falini B, Fizzotti M, Pucciarini A, Bigerna B, Marafioti T, Gambacorta M et al. A monoclonal antibody (MUM1p) detects expression of the MUM1\/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood 2000; 95: 2084\u20132092.","journal-title":"Blood"},{"issue":"Suppl. 1","key":"BFleu2008320_CR32","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1023\/A:1008300325610","volume":"11","author":"M Chesi","year":"2000","unstructured":"Chesi M, Kuehl WM, Bergsagel PL . Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma. Ann Oncol 2000; 11 (Suppl. 1): 131\u2013135.","journal-title":"Ann Oncol"},{"key":"BFleu2008320_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-4608(01)00436-8","volume":"129","author":"A Tamura","year":"2001","unstructured":"Tamura A, Miura I, Iida S, Yokota S, Horiike S, Nishida K et al. Interphase detection of immunoglobulin heavy chain gene translocations with specific oncogene loci in 173 patients with B-cell lymphoma. Cancer Genet Cytogenet 2001; 129: 1\u20139.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFleu2008320_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/sj.leu.2403543","volume":"19","author":"L Michaux","year":"2005","unstructured":"Michaux L, Wlodarska I, Rack K, Stul M, Criel A, Maerevoet M et al. Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in \u2018unmutated\u2019; B-CLL. Leukemia 2005; 19: 77\u201382.","journal-title":"Leukemia"},{"key":"BFleu2008320_CR35","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/0145-2126(85)90104-3","volume":"9","author":"C Mecucci","year":"1985","unstructured":"Mecucci C, Michaux JL, Tricot G, Louwagie A, den Berghe H . Rearrangements of the short arm of chromosome no. 6 in T-cell lymphomas. Leuk Res 1985; 9: 1139\u20131148.","journal-title":"Leuk Res"},{"key":"BFleu2008320_CR36","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/(SICI)1098-2264(199806)22:2<114::AID-GCC5>3.0.CO;2-#","volume":"22","author":"G Ott","year":"1998","unstructured":"Ott G, Katzenberger T, Siebert R, DeCoteau JF, Fletcher JA, Knoll JH et al. Chromosomal abnormalities in nodal and extranodal CD30+ anaplastic large cell lymphomas: infrequent detection of the t(2;5) in extranodal lymphomas. Genes Chromosomes Cancer 1998; 22: 114\u2013121.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFleu2008320_CR37","unstructured":"Mitelman F, Johansson B, Mertens F (eds). Mitelman Database of Chromosome Aberrations in Cancer (http:\/\/cgap.nci.nih.gov\/Chromosomes\/Mitelman 2007)."},{"key":"BFleu2008320_CR38","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1073\/pnas.96.6.2949","volume":"96","author":"Y Pekarsky","year":"1999","unstructured":"Pekarsky Y, Hallas C, Isobe M, Russo G, Croce CM . Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes. Proc Natl Acad Sci USA 1999; 96: 2949\u20132951.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2008320_CR39","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/gcc.20490","volume":"46","author":"C Almire","year":"2007","unstructured":"Almire C, Bertrand P, Ruminy P, Maingonnat C, Wlodarska I, Martin-Subero JI et al. PVRL2 is translocated to the TRA@ locus in t(14;19)(q11;q13)-positive peripheral T-cell lymphomas. Genes Chromosomes Cancer 2007; 46: 1011\u20131018.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFleu2008320_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/path.2196","volume":"213","author":"E Leich","year":"2007","unstructured":"Leich E, Haralambieva E, Zettl A, Chott A, Rudiger T, Holler S et al. Tissue microarray-based screening for chromosomal breakpoints affecting the T-cell receptor gene loci in mature T-cell lymphomas. J Pathol 2007; 213: 99\u2013105.","journal-title":"J Pathol"},{"key":"BFleu2008320_CR41","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/sj.leu.2401696","volume":"14","author":"K Tsuboi","year":"2000","unstructured":"Tsuboi K, Iida S, Inagaki H, Kato M, Hayami Y, Hanamura I et al. MUM1\/IRF4 expression as a frequent event in mature lymphoid malignancies. Leukemia 2000; 14: 449\u2013456.","journal-title":"Leukemia"},{"key":"BFleu2008320_CR42","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/modpathol.3880373","volume":"14","author":"Y Natkunam","year":"2001","unstructured":"Natkunam Y, Warnke RA, Montgomery K, Falini B, Van De Rijn M . Analysis of MUM1\/IRF4 protein expression using tissue microarrays and immunohistochemistry. Mod Pathol 2001; 14: 686\u2013694.","journal-title":"Mod Pathol"},{"key":"BFleu2008320_CR43","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.humpath.2007.08.013","volume":"39","author":"MJ Wasco","year":"2008","unstructured":"Wasco MJ, Fullen D, Su L, Ma L . The expression of MUM1 in cutaneous T-cell lymphoproliferative disorders. Hum Pathol 2008; 39: 557\u2013563.","journal-title":"Hum Pathol"},{"key":"BFleu2008320_CR44","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1038\/sj.leu.2404856","volume":"21","author":"J Iqbal","year":"2007","unstructured":"Iqbal J, Greiner TC, Patel K, Dave BJ, Smith L, Ji J et al. Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia 2007; 21: 2332\u20132343.","journal-title":"Leukemia"},{"key":"BFleu2008320_CR45","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1111\/j.1365-2133.2008.08566.x","volume":"158","author":"W Kempf","year":"2008","unstructured":"Kempf W, Kutzner H, Cozzio A, Sander CA, Pfaltz MC, Muller B et al. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Br J Dermatol 2008; 158: 1280\u20131287.","journal-title":"Br J Dermatol"},{"key":"BFleu2008320_CR46","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1182\/blood-2007-08-108654","volume":"111","author":"WL Zhao","year":"2008","unstructured":"Zhao WL, Liu YY, Zhang QL, Wang L, Leboeuf C, Zhang YW et al. PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor. Blood 2008; 111: 3867\u20133871.","journal-title":"Blood"},{"key":"BFleu2008320_CR47","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","volume":"111","author":"SK Kumar","year":"2008","unstructured":"Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood 2008; 111: 2516\u20132520.","journal-title":"Blood"},{"key":"BFleu2008320_CR48","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1200\/JCO.2007.11.4207","volume":"25","author":"PL Zinzani","year":"2007","unstructured":"Zinzani PL, Musuraca G, Tani M, Stefoni V, Marchi E, Fina M et al. Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma. J Clin Oncol 2007; 25: 4293\u20134297.","journal-title":"J Clin Oncol"},{"key":"BFleu2008320_CR49","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1182\/blood-2004-07-2911","volume":"105","author":"RZ Orlowski","year":"2005","unstructured":"Orlowski RZ, Voorhees PM, Garcia RA, Hall MD, Kudrik FJ, Allred T et al. Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies. Blood 2005; 105: 3058\u20133065.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2008320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2008320","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2008320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:25:15Z","timestamp":1648729515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2008320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,6]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["BFleu2008320"],"URL":"https:\/\/doi.org\/10.1038\/leu.2008.320","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,6]]},"assertion":[{"value":"7 May 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}